These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9124867)

  • 1. Efficacy of continuous flucytosine infusion against Candida lusitaniae in experimental hematogenous murine candidiasis.
    Karyotakis NC; Anaissie EJ
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2907-8. PubMed ID: 9124867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between in vitro and in vivo activity of antifungal agents against Candida species.
    Anaissie EJ; Karyotakis NC; Hachem R; Dignani MC; Rex JH; Paetznick V
    J Infect Dis; 1994 Aug; 170(2):384-9. PubMed ID: 8035024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections.
    Karyotakis NC; Dignani MC; Hachem R; Anaissie EJ
    Antimicrob Agents Chemother; 1995 Feb; 39(2):571-3. PubMed ID: 7726538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
    Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
    Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of escalating doses of liposomal amphotericin B (AmBisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice.
    Karyotakis NC; Anaissie EJ
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2660-2. PubMed ID: 7872764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing.
    Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Walsh TJ; Denning DW; Drusano GL
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3760-2. PubMed ID: 17682101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo characterization of the pharmacodynamics of flucytosine in a neutropenic murine disseminated candidiasis model.
    Andes D; van Ogtrop M
    Antimicrob Agents Chemother; 2000 Apr; 44(4):938-42. PubMed ID: 10722494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice.
    Atkinson BA; Bouthet C; Bocanegra R; Correa A; Luther MF; Graybill JR
    J Antimicrob Chemother; 1995 May; 35(5):631-40. PubMed ID: 7592176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice.
    Titsworth E; Grunberg E
    Antimicrob Agents Chemother; 1973 Sep; 4(3):306-8. PubMed ID: 4586144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.
    Karyotakis NC; Dignani MC; Anaissie EJ
    Antimicrob Agents Chemother; 1995 Mar; 39(3):775-7. PubMed ID: 7793892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice.
    Graybill JR; Najvar LK; Holmberg JD; Luther MF
    Antimicrob Agents Chemother; 1995 Apr; 39(4):924-9. PubMed ID: 7785997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of fungal peritonitis with a combination of intravenous amphotericin B and oral flucytosine, and delayed catheter replacement in continuous ambulatory peritoneal dialysis.
    Wong PN; Lo KY; Tong GM; Chan SF; Lo MW; Mak SK; Wong AK
    Perit Dial Int; 2008; 28(2):155-62. PubMed ID: 18332451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined antifungal therapy in a murine infection by Candida glabrata.
    Mariné M; Serena C; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents.
    Favel A; Michel-Nguyen A; Datry A; Challier S; Leclerc F; Chastin C; Fallague K; Regli P
    J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voriconazole and posaconazole therapy for experimental Candida lusitaniae infection.
    Sanchis M; Guarro J; Sutton DA; Fothergill AW; Wiederhold N; Capilla J
    Diagn Microbiol Infect Dis; 2016 Jan; 84(1):48-51. PubMed ID: 26456387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections.
    Girmenia C; Venditti M; Martino P
    Diagn Microbiol Infect Dis; 2003 Jul; 46(3):227-31. PubMed ID: 12867100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia.
    Thaler M; Bacher J; O'Leary T; Pizzo PA
    J Infect Dis; 1988 Jul; 158(1):80-8. PubMed ID: 3392423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice.
    Polak A; Scholer HJ; Wall M
    Chemotherapy; 1982; 28(6):461-79. PubMed ID: 6297858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
    Polak A
    Chemotherapy; 1987; 33(5):381-95. PubMed ID: 2822362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.